Liposomes with Differential Lipid Components Exert Differential Adjuvanticity in Antigen-Liposome Conjugates via Differential Recognition by Macrophages

Bioconjugate Chemistry

Volumn 15, Issue 1, 2004, Pages 35-40

  Tanaka, Yuriko ^a   Kasai, Michiyuki ^a   Taneichi, Maiko ^a   Naito, Seishiro ^a   Kato, Hiroshi ^a   Mori, Masahito ^b   Nishida, Mitsuhiro ^b   Maekawa, Naoya ^b   Yamamura, Hiroyuki ^b   Komuro, Katsutoshi ^a   Uchida, Tetsuya ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b JAPAN ENERGY CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS; CLONING; CYTOLOGY; MACROPHAGES; T-CELLS;

ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELLS; CELL CLONES; GLUTARALDEHYDES; IMMUNE RESPONSE; IN-VIVO; MACROPHAGE CULTURE; T CELL ACTIVATION;

LIPOSOMES;

ADJUVANT; ANTIGEN; LIPOSOME;

ADJUVANTICITY; ADOLESCENT; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; COCULTURE; CONJUGATION; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; LIPID COMPOSITION; LYMPHOCYTE CLONE; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 10744219535     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc034134o     Document Type: Article

References (30)

1. Audibert, F. M., and Lise, D. (1993) Adjuvants: current status, clinical perspectives and future prospects. Immunol. Today 14, 281-284.
2. Gupta, R. K., and Siber, G. R. (1995) Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13, 1263-1276.
3. O'Hagan, D. T. (2001) Recent developments in vaccine delivery systems. Curr. Drug Targets - Infect. Disorders 1, 273-286.
4. Mark, A., Bjorksten, B., and Granstrom, M. (1995) Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminum-adsorbed and fluid DT-vaccines. Vaccine 13, 669-673.
5. Aggrebeck, H., Wantzin, J., and Heon, I. (1996) Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations - III. Vaccine 14, 1265-1272.
6. Nothdurft, H. D., Jelinek, T., Marschang, A., Maiwald, H., Kapaun, A., and Loscher, T. (1996) Adverse reactions to Japanese encephalitis vaccine in travelers. J. Infect. 32, 119-122.
7. Gregoriadis, G. (1990) Immunological adjuvants: a role for liposomes. Immunol. Today 11, 89-97.
8. Gregoriadis, G. (1994) Liposomes as immunoadjuvants and vaccine carriers: antigen entrapment. ImmunoMethods 4, 210-216.
9. Wassef, N. M., Alving, C. R., and Richards, R. L. (1994) Liposomes as carriers for vaccines. ImmunoMethods 4, 217-222.
10. Alving, C. R., Koulchin, V., Glenn, G. M., and Rao, M. (1995) Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol. Rev. 145, 5-31.
11. Green, S., Fortier, J. D., Madsen, J., Swartz, G., Einck, L., Gubish, E., and Nacy, C. (1995) Liposomal vaccines. Immunology of Proteins and Peptides VIII (M. Z. Atassi, and G. S. Bixler, Eds.) pp 83-92, Plenum Press, New York.
12. De Haan, A., Tomee, J. F. C., Huchshorn, J. P., and Wilschut, J. (1995) Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. Vaccine 13, 1320-1324.
13. Gluck, R. (1995) Liposomal presentation of antigens for human vaccines. Pharm. Biotechnol. 6, 325-345.
14. Perrie, Y., Frederik, P. M., and Gregoriadis, G. (2001) Liposome-mediated DNA vaccination: the effect of vesicle composition. Vaccine 19, 3301-3310.
15. Naito, S., Horino, A., Nakayama, M., Nakano, Y., Nagai, T., Mizuguchi, J., Komuro, K., and Uchida, T. (1996) Ovalbumin-liposome conjugate induces IgG but not IgE antibody production. Int. Arch. Allergy Immunol. 109, 223-228.
16. Nakano, Y., Mori, M., Nishinohara, S., Takita, Y., Naito, S., Horino, A., Kato, H., Taneichi, M., Ami, Y., Suzaki, Y., Komuro, K., and Uchida, T. (1999) Antigen-specific, IgE selective unresponsiveness induced by antigen-liposome conjugates. Int. Arch. Allergy Immunol. 120, 199-208.
17. Naito, S., Taneichi, M., Kato, H., Tanaka, Y., Ami, Y., Suzaki, Y., Mori, M., Nakano, Y., Yamamura, H., Morokuma, K., Ohkuma, K., Miyake, H., Kiniwa, M., Komuro, K., and Uchida, T. (2002) Selective inhibition of systemic anti-OVA IgE production in response to oral preadministration with OVA-liposome conjugates. Int. Arch. Allergy Immunol. 129, 314-319.
18. Yoshikawa, T., Uchida, T., Naito, S., Horino, A., Taneichi, M., Kato, H., Komuro, K., Nakano, Y., Mori, M., Nishinohara, S., Chiba, J., Kurata, T., and Tamura, S. (2000) Suppression of IgE antibody response to ovalbumin by intranasal administration of liposome-conjugated ovalbumin. Int. Arch. Allergy Immunol. 121, 108-115.
19. Nakano, Y., Mori, M., Nishinohara, S., Takita, Y., Naito, S., Kato, H., Taneichi, M., Komuro, K., and Uchida, T. (2001) Surface-linked liposomal antigen induces IgE-selective unresponsiveness regardless of the lipid components of liposomes. Bioconjugate Chem. 12, 391-395.
20. Chang, E. Y., Zheng, Y., Holowka, D., and Baird, B. (1995) Alteration of lipid composition modulates FCεRI signaling in RBL-2H3 cells. Biochemistry 34, 4376-4384.
21. Phillips, N. C., Gagne, L., Ivanoff, N., and Riveau, G. (1996) Influence of phospholipid composition on antibody responses to liposome encapsulated protein and peptide antigens. Vaccine 14, 898-904.
22. Guan, H. H., Budzynski, W., Koganty, R. R., Krantz, M. J., Reddish, M. A., Rogers, J. A., Longenecker, M., and Samuel, J. (1998) Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptide on immune responses. Bioconjugate Chem. 9, 451-458.
23. Hincha, D. K., Oliver, A. E., and Crowe, J. H. (1999) Lipid composition determines the effect of arbutin on the stability of membranes. Biophys. J. 77, 2024-2034.
24. Moody, D. B., Briken, V., Cheng, T.-Y., Roura-Mir, C., Guy, M. R., Geho, D. H., Tykocinski, M. L., Besra, G. S., and Porcelli, S. A. (2002) Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat. Immunol. 3, 435-442.
25. Fortin, A., Shaum, E., Krzystyniak, K., and Therien, HM. (1996) Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens. Cell. Immunol. 169, 208-217.
26. Shahum, E., and Therien, H. M. (1988) Immunopotentiation of the humoral response by liposomes: encapsulation versus covalent linkage. Immunol. 65, 315-317.
27. Uchida, T., Ju, S. T., Fay, A., Liu, Y. N., and Dorf, M. E. (1985) Functional analysis of macrophage hybridomas. I. Production and initial characterization. J. Immunol. 134, 772-778.
28. Kakiuchi, T., Watanabe, M., Hozumi, N., and Nariuchi, H. (1990) Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J. Immunol. 145, 1653-1658.
29. Taneichi, M., Naito, S., Kato, H., Komuro, K., and Uchida, T. (2002) T cell-independent regulation of IgE antibody production induced by surface-linked liposomal antigen. J. Immunol 169, 4246-4252.
30. White, W. I., Cassatt, D. R., Madsen, J., Burke, S. J., Woods, R. M., Wassef, N. M., Alving, C. R., and Koenig, S. (1995) Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine 13, 1111-1122.